ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Infectious Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,500Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 208

$4.59M Total Retail Price of All Prescriptions

Rank: 2 out of 208

235 Patients Receiving at Least One Drug in Part D
8%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

33% of this provider’s 235 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

52% of this provider’s 235 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

0% of this provider’s 721 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

47% of this provider’s prescriptions were for brand-name drugs, compared to an average of 43%.

Prescription Price

$340 was the average price of a prescription from this provider, compared to $300 among peers.

Prescriptions per Patient

57 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
TRUVADA 699 60 10 1 2
HYDROCODONE-ACETAMINOPHEN 664 18 S3 2 3
ISENTRESS 644 33 10 3 4
NORVIR 482 26 4 1
INTELENCE 401 0 10 5 23
OMEPRAZOLE 395 20 6 8
EPZICOM 370 18 10 7 10
PREZISTA 352 27 8 7
LISINOPRIL 297 0 9 5
METHADONE HCL 257 25 S2 10 65
PRAVASTATIN SODIUM 246 13 11 18
IBUPROFEN 246 0 11 33
ACYCLOVIR 245 0 13 17
PROAIR HFA 206 21 14 43
REYATAZ 187 11 15 6
BUPROPION HCL SR 184 0 16 93
SULFAMETHOXAZOLE-TRIMETHOPRIM 183 0 17 21
MORPHINE SULFATE ER 177 0 S2 18 88
SELZENTRY 174 13 10 19 63
OXYCONTIN 170 0 S2 20 112
LYRICA 147 0 21 78
TRAZODONE HCL 146 0 22 38
KETOCONAZOLE 142 11 23 97
ATRIPLA 139 0 24 16
HYDROMORPHONE HCL 137 0 S2 25 145
HYDROCHLOROTHIAZIDE 134 0 26 19
FUROSEMIDE 133 0 27 24
NAPROXEN 129 0 28 70
TAMSULOSIN HCL 118 19 29 34
TESTOSTERONE CYPIONATE 110 17 S3 30 60
CYMBALTA 104 0 31 66
GABAPENTIN 104 13 31 13
DRONABINOL 103 0 33 75
ONDANSETRON HCL 88 13 34 172
CARISOPRODOL 88 0 R 34 107
TRIAMCINOLONE ACETONIDE 87 0 36 62
ANDROGEL 82 0 S3 37 30
METFORMIN HCL 81 0 38 15
FLUCONAZOLE 81 0 38 28
ATORVASTATIN CALCIUM 77 13 40 14
VENTOLIN HFA 77 0 40 155
AMLODIPINE BESYLATE 76 21 42 11
ATENOLOL 74 14 43 22
LEVOXYL 73 0 44 112
VIREAD 72 0 45 26
ZOLPIDEM TARTRATE 70 0 46 20
LAMIVUDINE 70 0 46 101
FENTANYL 69 0 S2 48 122
METOPROLOL SUCCINATE 68 0 49 54
PROMETHAZINE HCL 67 0 R 50 139
SUSTIVA 66 12 51 51
WARFARIN SODIUM 63 0 52 35
CYCLOBENZAPRINE HCL 62 0 R 53 134
OXYCODONE HCL 61 0 S2 54 158
AMPHETAMINE SALT COMBO 60 0 S2 55 163
FENOFIBRATE 59 0 56 44
LOVAZA 57 12 57 61
BENAZEPRIL HCL 55 13 58 29
LEVOTHYROXINE SODIUM 54 0 59 12
GEMFIBROZIL 53 0 60 74
CITALOPRAM HBR 52 0 61 40
VIRAMUNE XR 51 0 62 42
LANSOPRAZOLE 51 11 62 137
HYDROXYZINE HCL 50 0 R 64 143
ABILIFY 50 0 64 138
VIRAMUNE 50 13 64 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 2, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.